NasdaqGS - Nasdaq Real Time Price USD

ImmunityBio, Inc. (IBRX)

Compare
3.5712 +0.0812 (+2.33%)
As of 10:24 AM EDT. Market Open.
All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating Cash Flow
-410,003.0000
-366,757.0000
-337,509.0000
-274,419.0000
-171,724.0000
--
Investing Cash Flow
-100,494.0000
-30,470.0000
27,297.0000
-84,886.0000
-19,812.0000
--
Financing Cash Flow
597,160.0000
558,341.0000
233,613.0000
505,443.0000
150,675.0000
--
End Cash Position
130,493.0000
265,787.0000
104,965.0000
181,280.0000
35,094.0000
--
Income Tax Paid Supplemental Data
21.0000
8.0000
2.0000
9.0000
8.0000
--
Interest Paid Supplemental Data
99,563.0000
77,192.0000
35,442.0000
2,106.0000
40.0000
--
Capital Expenditure
-15,615.0000
-30,584.0000
-99,391.0000
-33,563.0000
-1,669.0000
--
Issuance of Capital Stock
52,934.0000
110,103.0000
60,427.0000
164,530.0000
86,302.0000
--
Issuance of Debt
199,000.0000
258,700.0000
174,125.0000
338,500.0000
63,700.0000
--
Repayment of Debt
-81.0000
-77.0000
-58.0000
--
--
--
Repurchase of Capital Stock
--
--
--
--
--
-2,501.0000
Free Cash Flow
-425,618.0000
-397,341.0000
-436,900.0000
-307,982.0000
-173,393.0000
--
12/31/2019 - 7/28/2015

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers